Wikidata

(Q44212082)

English

Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.

scientific article published in October 2002

In more languages

Statements

title
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12425755
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12425755%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44212082&oldid=2108586532"